Actavis Recalls Remaining Patches as a Precaution

Greg Owen

Attorney

0 CommentsPrint ArticleSubscribe

Actavis Inc., announced that its subsidiary Actavis South Atlantic LLC is moving forward with the recall of all of the Fentanyl transdermal system CII patches that were sold in the U. S.

The concern pertains to a possible defect that could cause a leakage of the fentanyl gel. Initally, 14 lots of the patches were recalled. However, it is unknown if the defect is present in patches that are still available to the public. Accordingly, Actavis Inc. has expanded its original recall. The patches in question were manufactured by Corium International Inc. The recall does not include Fentanyl patches sold in Europe. Fentanyl is a potent opioid medication. Using the defect patch could cause respiratory depression and possible overdose, which could be fatal. If you have purchased this product, please go to the link provided for additional information.

Additional Information Pertaining to Dangerous and Defective Products